Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.

Abstract

This study aims to establish the relative effectiveness and safety of low molecular weight heparin in elderly patients with venous thrombosis in order to find an alternative to oral anticoagulant therapy with less bleeding complications in the long-term treatment of deep venous thrombosis (DVT). One hundred consecutive elderly patients (>75 years old) with… (More)

Topics

Cite this paper

@article{Veiga2000LowMW, title={Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.}, author={F Veiga and Abel Escrib{\`a} and Mar{\'i}a P Maluenda and Montserrat L{\'o}pez Rubio and In{\'e}s Margalet and Antonio Hern{\'a}ndez Lezana and Juan Jose Gallego and Josep- Maria Ribera}, journal={Thrombosis and haemostasis}, year={2000}, volume={84 4}, pages={559-64} }